These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31301340)
1. Tumor-specific delivery of gemcitabine with activatable liposomes. Tucci ST; Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Foiret J; Hubbard NE; Borowsky AD; Baikoghli M; Cheng RH; Ferrara KW J Control Release; 2019 Sep; 309():277-288. PubMed ID: 31301340 [TBL] [Abstract][Full Text] [Related]
2. Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer? Tang M; Svirskis D; Leung E; Kanamala M; Wang H; Wu Z J Control Release; 2019 Jul; 305():89-100. PubMed ID: 31096017 [TBL] [Abstract][Full Text] [Related]
8. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models. Matsumoto T; Komori T; Yoshino Y; Ioroi T; Kitahashi T; Kitahara H; Ono K; Higuchi T; Sakabe M; Kori H; Kano M; Hori R; Kato Y; Hagiwara S Pharm Res; 2021 Jun; 38(6):1093-1106. PubMed ID: 33961188 [TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer. Dora CP; Kushwah V; Yadav V; Kuche K; Jain S Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900 [TBL] [Abstract][Full Text] [Related]
10. PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation. Kanamala M; Palmer BD; Ghandehari H; Wilson WR; Wu Z Pharm Res; 2018 May; 35(8):154. PubMed ID: 29855807 [TBL] [Abstract][Full Text] [Related]
15. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells. Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234 [TBL] [Abstract][Full Text] [Related]
16. Effective light-triggered contents release from helper lipid-incorporated liposomes co-encapsulating gemcitabine and a water-soluble photosensitizer. Fuse T; Tagami T; Tane M; Ozeki T Int J Pharm; 2018 Apr; 540(1-2):50-56. PubMed ID: 29410222 [TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive Nanoparticles Composed Solely of Membrane-Disruptive Macromolecules for Treating Pancreatic Cancer. Fan F; Jin L; Yang L ACS Appl Mater Interfaces; 2021 Mar; 13(11):12824-12835. PubMed ID: 33689289 [TBL] [Abstract][Full Text] [Related]
18. A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability. Li PW; Luo S; Xiao LY; Tian BL; Wang L; Zhang ZR; Zeng YC Acta Pharmacol Sin; 2019 Nov; 40(11):1448-1456. PubMed ID: 31015736 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles. Ruan JL; Browning RJ; Yildiz YO; Bau L; Kamila S; Gray MD; Folkes L; Hampson A; McHale AP; Callan JF; Vojnovic B; Kiltie AE; Stride E Ultrasound Med Biol; 2021 Jun; 47(6):1596-1615. PubMed ID: 33707089 [TBL] [Abstract][Full Text] [Related]
20. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic. Papa AL; Sidiqui A; Balasubramanian SU; Sarangi S; Luchette M; Sengupta S; Harfouche R Cell Oncol (Dordr); 2013 Dec; 36(6):449-57. PubMed ID: 24081907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]